Search results

Membership details, terms of reference, future meeting dates and past meeting minutes for our indicator advisory committee.

Home What NICE does Our guidance About HealthTech guidance...

An approximate guide to the timings for the development of a piece of HealthTech guidance.

Our HealthTech Programme considers technologies that could offer benefits to patients and the health and social care system over current practice.

We want you to be involved in our work - whether you’re commenting on our draft recommendations, taking part in guidance development or attending a committee meeting, your voice is important to us.

Evidence-based recommendations on cryotherapy for malignant endobronchial obstruction. This involves using cold temperatures to destroy the cancer tissue that’s causing a blockage.

Result type

HealthTech guidance

Published

23 November 2005

Evidence-based recommendations on photodynamic therapy (PDT) for localised inoperable endobronchial cancer (non-small-cell lung cancer). This involves injecting a photosensitising agent into the body that is activated by laser light to destroy the cancerous tissue.

Result type

HealthTech guidance

Published

23 November 2005

Evidence-based recommendations on endoscopic duodenal mucosal resurfacing for insulin resistance in type 2 diabetes. This involves using heat to destroy the lining of the duodenum to encourage a new lining to grow.

Result type

HealthTech guidance

Published

16 May 2024

Evidence-based recommendations on radiofrequency ablation for atrial fibrillation in association with other cardiac surgery. This involves scarring the heart tissue using heat to interrupt abnormal electrical signals.

Result type

HealthTech guidance

Published

25 May 2005

Evidence-based recommendations on irreversible electroporation for treating primary lung cancer and metastases in the lung. This involves using electrical pulses to kill cancer cells.

Result type

HealthTech guidance

Published

23 February 2013

Evidence-based recommendations on percutaneous radiofrequency ablation for primary or secondary lung cancers. This involves inserting 1 or more electrodes (needle-like probes) through the chest into the lung and using an electrical current to produce heat to destroy the cancer cells.

Result type

HealthTech guidance

Published

15 December 2010

Evidence-based recommendations on endobronchial ultrasound-guided transbronchial biopsy for peripheral lung lesions. This involves inserting an ultrasound probe via the patient’s nose or mouth into the lungs to obtain images as a guide for taking samples of the lesions.

Result type

HealthTech guidance

Published

24 March 2010

Evidence-based recommendations on endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal masses. This involves inserting a thin tube through the mouth into the lungs to take samples for examination.

Result type

HealthTech guidance

Published

27 February 2008

Evidence-based recommendations on living-donor lung transplantation for end-stage lung disease. This involves removing a lung from each of the two donors and replacing the recipient's lungs with the donor lungs.

Result type

HealthTech guidance

Published

24 May 2006

Home What NICE does Our guidance About HealthTech guidance...